Crossmark

Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy

Crossref DOI link: https://doi.org/10.1039/C8OB02902D

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Fernandes, Sara R. G. https://orcid.org/0000-0003-4905-2621
Fernandes, Rosa https://orcid.org/0000-0001-7828-2296
Sarmento, Bruno https://orcid.org/0000-0001-5763-7553
Pereira, Patrícia M. R.

Tomé, João P. C. https://orcid.org/0000-0001-6057-4936
Funding

Funding for this research was provided by:

Fundação para a Ciência e a Tecnologia (FCT UID/QUI/0100/2013, FCT UID/NEU/04539/2013, POCI-01-0145-FEDER-007440, POCI-01-0145-FEDER-007274, NORTE-01-0145-FEDER-000012, SFRH/BD/129200/2017)

European Regional Development Fund

Tow Foundation
License Information

Accepted Manuscript valid from 2020-01-08
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Sara R. G. Fernandes (ORCID)

: Rosa Fernandes (ORCID)

: Bruno Sarmento (ORCID)

: João P. C. Tomé (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 20 November 2018; Accepted 8 January 2019; Accepted Manuscript published 8 January 2019; Advance Article published 16 January 2019; Version of Record published 6 March 2019